Your AI-Trained Oncology Knowledge Connection!

Emerging CAR-T Therapies in Large B-cell Lymphomas (LBCL): Highlights from ASH 2022 and Beyond : Episode 1

Video

January 24, 2023

Overview of Large B-Cell Lymphoma (LBCL)

Author(s):

Manali Kamdar, MD,Matthew A. Lunning, DO, FACP

Experts discuss Large B-Cell Lymphoma (LBCL) and treatment strategies for patients with LBCL.

Now Viewing

EP: 1.Overview of Large B-Cell Lymphoma (LBCL)

EP: 2.Treatment Strategies for Patients with R/R LBCL

EP: 3.CAR T-Cell Therapy in R/R LBCL: TRANSFORM, ZUMA-7, and PILOT Studies

EP: 4.CAR T-Cell Therapy as Second-Line Treatment in LBCL

EP: 5.Choosing the Appropriate CAR T-Cell Therapy in Patients with R/R DLBCL

EP: 6.Additional Key Data Updates from ASH 2022 on Treatment of LBCL

EP: 7.Treatment Sequencing in LBCL: Clinical Trial and Real-World Data

EP: 8.Practice Pearls for Physicians Considering CAR T-cell Therapy for Patients with LBCL

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All

Multimedia

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

May 15th 2025 - May 16th 2026

online-activity

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

May 15th 2025 - May 16th 2026

online-activity

Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana

May 14th 2025 - Jun 19th 2025

online-activity

Latest Conference Coverage

T-DM1 Plus Palbociclib Displays Activity in HER2+ Metastatic Breast Cancer

EL1SSAR Data Shed Light on Leveraging Atezolizumab Plus Nab-Paclitaxel in PD-L1+ TNBC

Pretreatment ctDNA Status Is Associated With Distant Recurrent-Free Survival in Early Breast Cancer

Zanidatamab/Chemotherapy Yields Responses and Is Safe in HER2-Expressing Metastatic Breast Cancer

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

Overview of Large B-Cell Lymphoma (LBCL)

EP: 1.Overview of Large B-Cell Lymphoma (LBCL)

EP: 2.Treatment Strategies for Patients with R/R LBCL

EP: 3.CAR T-Cell Therapy in R/R LBCL: TRANSFORM, ZUMA-7, and PILOT Studies

EP: 4.CAR T-Cell Therapy as Second-Line Treatment in LBCL

EP: 5.Choosing the Appropriate CAR T-Cell Therapy in Patients with R/R DLBCL

EP: 6.Additional Key Data Updates from ASH 2022 on Treatment of LBCL

EP: 7.Treatment Sequencing in LBCL: Clinical Trial and Real-World Data

EP: 8.Practice Pearls for Physicians Considering CAR T-cell Therapy for Patients with LBCL

Newsletter

Latest CME

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | Indiana

Navigating the Glaucoma Therapeutic and Surgical Landscape: From Conventional to Cutting-Edge

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | Indiana

Navigating the Glaucoma Therapeutic and Surgical Landscape: From Conventional to Cutting-Edge

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | Indiana

Navigating the Glaucoma Therapeutic and Surgical Landscape: From Conventional to Cutting-Edge

Latest Conference Coverage